USPTO serial 97842648
PREDXBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 8, 2025
- Examiner
- GREEN, OCTAVIA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PREDXBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Pittsburgh, PA
Pittsburgh, PA
PITTSBURGH, PA
PITTSBURGH, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Victoria D. Summerfield
Victoria D. Summerfield TROUTMAN PEPPER HAMILTON SANDERS LLP501 GRANT STREET, SUITE 300, UNION TRUSTPITTSBURGH, PA 15219United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SAAS) services featuring web based pathology software, namely, web based image analysis software for use in the field of pathology; Software as a service (SAAS) services, featuring software for use in the field of pathology, namely, software that defines the spatial relationships between cells and molecules within tissue microenvironments to aid in the interpretation of patient tissue samples, predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services, featuring software for performing image analysis in the field of pathology, namely, in connection with transmitted light microscopy and fluorescence microscopy; Software as a service (SAAS) services, featuring software for reviewing and managing images and for digital pathology image management; Software as a service (SAAS) services, featuring software for use in cancer diagnosis, namely, software to predict metastatic potential in primary solid tumors; Software as a service (SAAS) services, featuring web based software for viewing, annotating, analyzing, and scoring digital slides, for consolidating case information, a score, results, a diagnosis, comments, and digital images into a pathology case report, for generating, exporting, and printing pathology case reports, and for providing audit trials in the field of pathology; Software as a service (SAAS) services, featuring web based software for remotely accessing pathology images, for remotely accessing pathology images and metadata, and for creating, assigning, and managing pathology cases; Providing an online searchable database featuring images for evaluating machine learning algorithms for computational pathology, for scientific and medical research purposes; medical research, namely, pathology evaluations utilizing image analysis algorithms; Medical and scientific research in the field of cancer treatment and diagnosis and consultation related thereto; medical and scientific research in the field of medical imaging and consultation related thereto; Software as a service (SAAS) services, featuring computer software for use in image analysis of digital images of tissue samples acquired by optical microscopy; Software as a service (SAAS) services, featuring computer software for creating tissue-based image analysis algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics; Software as a service (SAAS) services, featuring data processing software for tissue-based image analysis using algorithms; Software as a service, (SAAS) services, featuring data processing software for tissue-based image analysis using algorithms to predict patient outcomes, provide personalized therapeutic strategies, and develop diagnostics. | ACTIVE | Apr 23, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SpIntellx, Inc.
- Other trademarks owned by SpIntellx, Inc.
- Other trademarks owned by PREDXBIO, INC.
- Other trademarks owned by PREDXBIO, INC.
- Other trademarks in Class 042
- Similar marks named PREDXBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 8, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 8, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 17, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 8, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Dec 20, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 19, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 7, 2024 | IUAF | USE AMENDMENT FILED | — |
| Oct 7, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 16, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 31, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 16, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 16, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 16, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 13, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |